Related Experiment Video
Updated: Jul 10, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Interpreting measurements of physical function in clinical trials
1NIAMS/NIH, Building 10 CRC, Room 4-1339, 10 Center Drive, MSC 1468, Bethesda, MD 20892, USA. wardm1@mail.nih.gov
Functional limitations in rheumatic disease treatment response vary by cause. Acute symptoms improve with treatment, while structural damage causes irreversible limitations, impacting clinical trial interpretation.
Area of Science:
- Rheumatology
- Clinical Trials
- Rehabilitation Medicine
Background:
- Improving physical functioning is a primary goal of anti-rheumatic treatments.
- Functional limitations in patients with rheumatic diseases stem from diverse causes, impacting treatment response.
- Limitations due to acute symptoms are often reversible, unlike those from chronic structural changes.
Purpose of the Study:
- To analyze how the cause and duration of functional limitations affect treatment response in rheumatic diseases.
- To highlight the challenges in interpreting physical function measures in clinical trials due to sample heterogeneity.
- To emphasize the need to consider disease stage and structural damage when evaluating treatment efficacy.
Main Methods:
- Review of existing literature on physical functioning measures in rheumatic disease clinical trials.
- Analysis of factors influencing the responsiveness of physical function measures to anti-rheumatic treatments.
- Examination of how disease duration and structural damage affect patient outcomes and clinical trial interpretation.
Main Results:
- Functional limitations due to acute symptoms are more responsive to treatment than those from chronic structural damage.
- Patients with longer disease duration and more structural damage show less improvement in physical function.
- Heterogeneity in disease duration and structural damage within study samples complicates the interpretation of treatment effects.
Conclusions:
- The interpretation of physical function measurements in clinical trials must account for the underlying causes of limitations.
- Disease stage and structural damage significantly influence the ability to detect treatment-induced improvements in physical functioning.
- Considering sample composition, particularly disease duration and structural damage, is crucial for accurate assessment of anti-rheumatic treatment efficacy.
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Data: Statistical Interpretation
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

